Saturday, August 2, 2014

Is a $1,000 Pill Really Too Much? by MARGOT SANGER-KATZ



By MARGOT SANGER-KATZ


Critics have raised an outcry over Sovaldi, a hepatitis C drug heralded as a breakthrough but costing $84,000 for a typical person’s total treatment.


Published: August 3, 2014 at 4:00AM


from NYT The Upshot http://ift.tt/1sfYdFs

via IFTTT








from WordPress http://ift.tt/1ojJjfQ
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)